HLA reduces killer cell Ig-like receptor expression level and frequency in a humanized mouse model

Journal of Immunology

Volumn 190, Issue 6, 2013, Pages 2880-2885

  Van Bergen, Jeroen ^a   Thompson, Allan ^a   Van Pel, Melissa ^a   Retière, Christelle ^b   Salvatori, Daniela ^a   Raulet, David H ^c   Trowsdale, John ^d   Koning, Frits ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITÉ DE NANTES   (France)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; LIGAND; NATURAL KILLER CELL RECEPTOR NKG2A; PROTEIN KIR2DL2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL SURFACE; CELL TYPE; CONTROLLED STUDY; GENE LOCUS; GENETIC VARIABILITY; HAPLOTYPE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; TRANSGENE; TRANSGENIC MOUSE;

ANIMALS; H-2 ANTIGENS; HLA-C ANTIGENS; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE DEPLETION; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, KNOCKOUT; MICE, TRANSGENIC; MODELS, IMMUNOLOGICAL; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY C; RECEPTORS, KIR; RECEPTORS, KIR2DL2;

EID: 84874923644     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1200650     Document Type: Article

References (33)

1. Parham, P. 2005. MHC class I molecules and KIRs in human history, health and survival. Nat. Rev. Immunol. 5: 201-214.
2. Carr, W. H., M. J. Pando, and P. Parham. 2005. KIR3DL1 polymorphisms that affect NK cell inhibition by HLA-Bw4 ligand. J. Immunol. 175: 5222-5229.
3. Höglund, P., and P. Brodin. 2010. Current perspectives of natural killer cell education by MHC class I molecules. Nat. Rev. Immunol. 10: 724-734.
4. Valiante, N. M., M. Uhrberg, H. G. Shilling, K. Lienert-Weidenbach, K. L. Arnett, A. D'Andrea, J. H. Phillips, L. L. Lanier, and P. Parham. 1997. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity 7: 739-751.
5. Gumperz, J. E., N. M. Valiante, P. Parham, L. L. Lanier, and D. Tyan. 1996. Heterogeneous phenotypes of expression of the NKB1 natural killer cell class I receptor among individuals of different human histocompatibility leukocyte antigens types appear genetically regulated, but not linked to major histocompatibility complex haplotype. J. Exp. Med. 183: 1817-1827.
6. Shilling, H. G., N. Young, L. A. Guethlein, N. W. Cheng, C. M. Gardiner, D. Tyan, and P. Parham. 2002. Genetic control of human NK cell repertoire. J. Immunol. 169: 239-247.
7. Anfossi, N., P. André, S. Guia, C. S. Falk, S. Roetynck, C. A. Stewart, V. Breso, C. Frassati, D. Reviron, D. Middleton, et al. 2006. Human NK cell education by inhibitory receptors for MHC class I. Immunity 25: 331-342.
8. Schönberg, K., M. Sribar, J. Enczmann, J. C. Fischer, and M. Uhrberg. 2011. Analyses of HLA-C-specific KIR repertoires in donors with group A and B haplotypes suggest a ligand-instructed model of NK cell receptor acquisition. Blood 117: 98-107.
9. Yawata, M., N. Yawata, M. Draghi, A. M. Little, F. Partheniou, and P. Parham. 2006. Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function. J. Exp. Med. 203: 633-645.
10. Yawata, M., N. Yawata, M. Draghi, F. Partheniou, A. M. Little, and P. Parham. 2008. MHC class I-specific inhibitory receptors and their ligands structure diverse human NK-cell repertoires toward a balance of missing self-response. Blood 112: 2369-2380.
11. Andersson, S., C. Fauriat, J. A. Malmberg, H. G. Ljunggren, and K. J. Malmberg. 2009. KIR acquisition probabilities are independent of self-HLA class I ligands and increase with cellular KIR expression. Blood 114: 95-104.
12. Wilson, M. J., M. Torkar, A. Haude, S. Milne, T. Jones, D. Sheer, S. Beck, and J. Trowsdale. 2000. Plasticity in the organization and sequences of human KIR/ ILT gene families. Proc. Natl. Acad. Sci. USA 97: 4778-4783.
13. Belkin, D., M. Torkar, C. Chang, R. Barten, M. Tolaini, A. Haude, R. Allen, M. J. Wilson, D. Kioussis, and J. Trowsdale. 2003. Killer cell Ig-like receptor and leukocyte Ig-like receptor transgenic mice exhibit tissue- and cell-specific transgene expression. J. Immunol. 171: 3056-3063.
14. van Bergen, J., A. Thompson, C. Retière, J. Trowsdale, and F. Koning. 2009. Cutting edge: killer Ig-like receptors mediate "missing self" recognition in vivo. J. Immunol. 182: 2569-2572.
15. Dill, O., F. Kievits, S. Koch, P. Ivanyi, and G. J. Hämmerling. 1988. Immunological function of HLA-C antigens in HLA-Cw3 transgenic mice. Proc. Natl. Acad. Sci. USA 85: 5664-5668.
16. Grigoriadou, K., C. Ménard, B. Pérarnau, and F. A. Lemonnier. 1999. MHC class Ia molecules alone control NK-mediated bone marrow graft rejection. Eur. J. Immunol. 29: 3683-3690.
17. Vance, R. E., A. M. Jamieson, and D. H. Raulet. 1999. Recognition of the class Ib molecule Qa-1(b) by putative activating receptors CD94/NKG2C and CD94/ NKG2E on mouse natural killer cells. J. Exp. Med. 190: 1801-1812.
18. Vance, R. E., A. M. Jamieson, D. Cado, and D. H. Raulet. 2002. Implications of CD94 deficiency and monoallelic NKG2A expression for natural killer cell development and repertoire formation. Proc. Natl. Acad. Sci. USA 99: 868-873.
19. David, G., M. Morvan, K. Gagne, N. Kerdudou, C. Willem, A. Devys, M. Bonneville, G. Folléa, J. D. Bignon, and C. Retière. 2009. Discrimination between the main activating and inhibitory killer cell immunoglobulin-like receptor positive natural killer cell subsets using newly characterized monoclonal antibodies. Immunology 128: 172-184.
20. Fernandez, N. C., E. Treiner, R. E. Vance, A. M. Jamieson, S. Lemieux, and D. H. Raulet. 2005. A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. Blood 105: 4416-4423.
21. Kim, S., J. Poursine-Laurent, S. M. Truscott, L. Lybarger, Y. J. Song, L. Yang, A. R. French, J. B. Sunwoo, S. Lemieux, T. H. Hansen, and W. M. Yokoyama. 2005. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 436: 709-713.
22. Oberg, L., S. Johansson, J. Michaëlsson, E. Tomasello, E. Vivier, K. Kärre, and P. Höglund. 2004. Loss or mismatch of MHC class I is sufficient to trigger NK cell-mediated rejection of resting lymphocytes in vivo - role of KARAP/DAP12- dependent and -independent pathways. Eur. J. Immunol. 34: 1646-1653.
23. Saulquin, X., L. N. Gastinel, and E. Vivier. 2003. Crystal structure of the human natural killer cell activating receptor KIR2DS2 (CD158j). J. Exp. Med. 197: 933-938.
24. van Bergen, J., A. Thompson, A. van der Slik, T. H. Ottenhoff, J. Gussekloo, and F. Koning. 2004. Phenotypic and functional characterization of CD4 T cells expressing killer Ig-like receptors. J. Immunol. 173: 6719-6726.
25. Moesta, A. K., P. J. Norman, M. Yawata, N. Yawata, M. Gleimer, and P. Parham. 2008. Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3. J. Immunol. 180: 3969-3979.
26. Fahlén, L., U. Lendahl, and C. L. Sentman. 2001. MHC class I-Ly49 interactions shape the Ly49 repertoire on murine NK cells. J. Immunol. 166: 6585-6592.
27. Saleh, A., G. E. Davies, V. Pascal, P. W. Wright, D. L. Hodge, E. H. Cho, S. J. Lockett, M. Abshari, and S. K. Anderson. 2004. Identification of probabilistic transcriptional switches in the Ly49 gene cluster: a eukaryotic mechanism for selective gene activation. Immunity 21: 55-66.
28. Davies, G. E., S. M. Locke, P. W. Wright, H. Li, R. J. Hanson, J. S. Miller, and S. K. Anderson. 2007. Identification of bidirectional promoters in the human KIR genes. Genes Immun. 8: 245-253.
29. Tanamachi, D. M., D. C. Moniot, D. Cado, S. D. Liu, J. K. Hsia, and D. H. Raulet. 2004. Genomic Ly49A transgenes: basis of variegated Ly49A gene expression and identification of a critical regulatory element. J. Immunol. 172: 1074-1082.
30. Johansson, S., M. Johansson, E. Rosmaraki, G. Vahlne, R. Mehr, M. Salmon- Divon, F. Lemonnier, K. Kärre, and P. Höglund. 2005. Natural killer cell education in mice with single or multiple major histocompatibility complex class I molecules. J. Exp. Med. 201: 1145-1155.
31. Kurepa, Z., C. A. Hasemann, and J. Forman. 1998. Qa-1b binds conserved class I leader peptides derived from several mammalian species. J. Exp. Med. 188: 973- 978.
32. Sivakumar, P. V., A. Gunturi, M. Salcedo, J. D. Schatzle, W. C. Lai, Z. Kurepa, L. Pitcher, M. S. Seaman, F. A. Lemonnier, M. Bennett, et al. 1999. Cutting edge: expression of functional CD94/NKG2A inhibitory receptors on fetal NK1.1+Ly-49- cells: a possible mechanism of tolerance during NK cell development. J. Immunol. 162: 6976-6980.
33. Sola, C., P. André, C. Lemmers, N. Fuseri, C. Bonnafous, M. Bléry, N. R. Wagtmann, F. Romagné, E. Vivier, and S. Ugolini. 2009. Genetic and antibody-mediated reprogramming of natural killer cell missing-self recognition in vivo. Proc. Natl. Acad. Sci. USA 106: 12879-12884.